Education
About Us
Working with TipRanks
Follow Us
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
Eli-002 7P
Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Kras G12d, Kras G12r, Kras G12v, Kras G12a, Kras G12c, Kras G12s, Kras G13d, Nras G12d, Nras G12r, Nras G12v, Nras G12c, Nras G12s
Phase I/II
Active Not Recruiting
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
Feb 03, 2023
―
Eli-002 2P
Ovarian Cancer, Colorectal Cancer, Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Bile Duct Cancer, Minimal Residual Disease, Cholangiocarcinoma, Gallbladder Carcinoma, Kras G12d, Kras G12r, Nras G12d, Nras G12r
Phase I
Completed
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
Apr 16, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Elicio Therapeutics (ELTX) have in its pipeline
ELTX is currently developing the following drugs: Eli-002 7P, Eli-002 2P. These drug candidates are in various stages of clinical development as the company works toward FDA approval.